Glutamine transporter upregulation driven by c-MYC has been reported previously59–61, but whether deregulated c-MYC33 drives this upregulation in CML LSCs warrants further investigation. This evidence concerns the gene MYC and chronic myelogenous leukemia, BCR-ABL1 positive.